Motif ID: E2f3
Z-value: 1.035
Transcription factors associated with E2f3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| E2f3 | ENSMUSG00000016477.11 | E2f3 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| E2f3 | mm10_v2_chr13_-_29984219_29984353 | 0.54 | 1.1e-06 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 8.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 2.4 | 11.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 1.6 | 6.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.5 | 4.5 | GO:0010752 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cGMP-mediated signaling(GO:0010752) negative regulation of plasminogen activation(GO:0010757) |
| 1.3 | 4.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 1.3 | 5.2 | GO:0035624 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) response to high density lipoprotein particle(GO:0055099) |
| 1.2 | 3.6 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
| 1.1 | 5.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 1.1 | 8.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 1.0 | 3.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.0 | 2.9 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
| 1.0 | 7.7 | GO:0033504 | floor plate development(GO:0033504) |
| 0.9 | 6.6 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.8 | 7.2 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.7 | 7.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.7 | 3.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.6 | 1.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.6 | 1.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.6 | 1.8 | GO:2000564 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) CD8-positive, alpha-beta T cell proliferation(GO:0035740) negative regulation of regulatory T cell differentiation(GO:0045590) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.6 | 1.7 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.5 | 3.8 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.5 | 1.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) cholangiocyte proliferation(GO:1990705) |
| 0.5 | 5.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.5 | 1.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.5 | 1.4 | GO:0000087 | mitotic M phase(GO:0000087) |
| 0.5 | 1.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.5 | 17.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.5 | 2.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.4 | 1.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.4 | 3.1 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.4 | 3.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.4 | 1.5 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.4 | 1.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 | 2.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.3 | 2.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.3 | 2.0 | GO:0042148 | strand invasion(GO:0042148) |
| 0.3 | 5.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.3 | 1.8 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.3 | 4.9 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.3 | 0.9 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.3 | 1.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 | 1.0 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.2 | 2.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 | 3.0 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 | 1.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.2 | 5.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 | 5.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.2 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.2 | 0.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 | 3.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 | 1.0 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.2 | 6.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.2 | 0.5 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 1.0 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.7 | GO:0046654 | 'de novo' IMP biosynthetic process(GO:0006189) tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 | 1.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 3.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 1.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 1.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.4 | GO:0072070 | loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.1 | 2.1 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 1.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 1.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 1.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.1 | 2.5 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 | 1.1 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.1 | 1.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 | 0.5 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.1 | 0.5 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.1 | 1.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 1.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 1.8 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.1 | 0.3 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 1.9 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 0.1 | 4.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 2.3 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.1 | 0.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 2.5 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.1 | 1.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 3.3 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 | 1.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 1.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.6 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.0 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.0 | 1.9 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.0 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.0 | 1.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.0 | 0.7 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.0 | 3.4 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.0 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.0 | 0.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
| 0.0 | 2.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 2.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 1.9 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.0 | 0.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 4.4 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
| 0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 3.8 | GO:0006310 | DNA recombination(GO:0006310) |
| 0.0 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.0 | 0.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.0 | 1.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 0.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 1.8 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.0 | 2.4 | GO:0007018 | microtubule-based movement(GO:0007018) |
| 0.0 | 1.6 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 2.1 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
| 0.0 | 0.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 20.4 | GO:0000796 | condensin complex(GO:0000796) |
| 1.5 | 4.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.4 | 7.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 1.3 | 6.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 1.1 | 4.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.0 | 5.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.9 | 6.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.8 | 8.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.5 | 1.5 | GO:0000811 | GINS complex(GO:0000811) |
| 0.5 | 1.8 | GO:0032021 | NELF complex(GO:0032021) |
| 0.5 | 1.4 | GO:0034679 | integrin alpha2-beta1 complex(GO:0034666) integrin alpha3-beta1 complex(GO:0034667) integrin alpha9-beta1 complex(GO:0034679) |
| 0.4 | 3.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 2.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.3 | 2.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.3 | 1.7 | GO:0000938 | GARP complex(GO:0000938) |
| 0.3 | 3.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.2 | 1.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 1.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) nuclear meiotic cohesin complex(GO:0034991) |
| 0.2 | 2.1 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 1.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 1.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.2 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.2 | 0.8 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
| 0.1 | 2.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 1.0 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 3.1 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 5.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 1.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 3.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.1 | 7.2 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 1.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 10.1 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 1.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 1.5 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 1.4 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 5.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 5.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 3.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 2.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 2.1 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 2.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
| 0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 2.1 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 2.5 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 1.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.4 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.0 | 3.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 1.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 3.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 6.6 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 1.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 4.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.4 | 7.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 1.3 | 4.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 1.2 | 3.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
| 1.1 | 6.6 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.7 | 5.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.7 | 5.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.6 | 1.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.6 | 3.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.6 | 3.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.5 | 2.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.5 | 1.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.5 | 1.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.4 | 2.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.4 | 6.1 | GO:0051010 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) microtubule plus-end binding(GO:0051010) |
| 0.4 | 2.0 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.4 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.4 | 1.1 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) hedgehog family protein binding(GO:0097108) |
| 0.3 | 1.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.3 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.3 | 1.1 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 1.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 1.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.2 | 6.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 4.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.2 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.2 | 3.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.2 | 3.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.2 | 8.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 1.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 1.3 | GO:0052872 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
| 0.1 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 8.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 1.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.1 | 0.4 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
| 0.1 | 0.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 5.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.1 | 1.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.1 | 7.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.1 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
| 0.1 | 3.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 1.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 1.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 1.5 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 3.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 2.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 2.2 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
| 0.1 | 0.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 1.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 2.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 1.4 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
| 0.0 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 12.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 4.2 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.5 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 1.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.0 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 1.7 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 10.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.0 | 1.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 2.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.7 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 0.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 1.3 | GO:0042277 | peptide binding(GO:0042277) |
